Genetics and Personalized Medicine—a Role in Statin Therapy? Jaideep PatelThura AbdH. Robert Superko Statin Drugs (MB Clearfield, Section Editor) 30 November 2013 Article: 384
The Spectrum of Statin Therapy in Cancer Patients: Is There a Need for Further Investigation? Michael J. Gonyeau Statin Drugs (MB Clearfield, Section Editor) 05 December 2013 Article: 383
Novel Therapies for Treating Familial Hypercholesterolemia Salman J. BandealiJad DayeSalim S. Virani Nonstatin Drugs (WB Borden, Section Editor) 30 November 2013 Article: 382
The Role of Glycemic Index and Glycemic Load In Cardiovascular Disease And Its Risk Factors: A Review of The Recent Literature Arash MirrahimiLaura ChiavaroliDavid J. A. Jenkins NUTRITION (BV HOWARD, SECTION EDITOR) 15 November 2013 Article: 381
The “New Deadly Quartet” for Cardiovascular Disease in the 21st Century: Obesity, Metabolic Syndrome, Inflammation and Climate Change: How Does Statin Therapy Fit into this Equation? Michael ClearfieldMelissa PearceAlesia Wagner Statin Drugs (MB Clearfield, Section Editor) 17 December 2013 Article: 380
Clinical and Biological Relevance of Statin-Mediated Changes in HDL Metabolism Benoit J. ArsenaultS. Matthijs Boekholdt Statin Drugs (MB Clearfield, Section Editor) 23 November 2013 Article: 379
Are There Any Benefits from Statin Treatment for the Septic Patient? Peter S. KrugerBala Venkatesh Statin Drugs (MB Clearfield, Section Editor) 26 November 2013 Article: 378
Statin Therapy in Heart Failure: For Good, for Bad, or Indifferent? Luisa De GennaroNatale Daniele BrunettiMatteo Di Biase Statin Drugs (MB Clearfield, Section Editor) 26 November 2013 Article: 377